Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2026/6/8 申報
- 申報編號
- 0001470831-26-000523
- 申報時間
- 2026/6/8
- 交易日
- 2026/6/4-6/5
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 14 筆非衍生性交易。公開市場賣出合計 $541.3 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/4 | Common Stock | S賣出處分 | −2,200 | $65.72F2 | −$144,584 | 553,486 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −1,429 | $66.72F4 | −$95,342.88 | 552,057 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −15,921 | $67.74F5 | −$1,078,488.54 | 536,136 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −450 | $68.27F6 | −$30,721.5 | 535,686 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −2,200 | $65.72F2 | −$144,584 | 4,356,247 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −1,429 | $66.72F4 | −$95,342.88 | 4,354,818 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −15,921 | $67.74F5 | −$1,078,488.54 | 4,338,897 | 間接 | |
| 2026/6/4 | Common Stock | S賣出處分 | −450 | $68.27F6 | −$30,721.5 | 4,338,447 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −7,147 | $67.20F7 | −$480,278.4 | 528,539 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −8,437 | $67.88F8 | −$572,703.56 | 520,102 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −4,416 | $68.96F9 | −$304,527.36 | 515,686 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −7,148 | $67.20F7 | −$480,345.6 | 4,331,299 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −8,437 | $67.88F8 | −$572,703.56 | 4,322,862 | 間接 | |
| 2026/6/5 | Common Stock | S賣出處分 | −4,415 | $68.96F9 | −$304,458.4 | 4,318,447 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $65.145 to $66.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $66.15 to $67.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $67.17 to $68.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $68.17 to $68.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F7
Represents the weighted average sale price of the shares sold from $66.59 to $67.58 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of the shares sold from $67.61 to $68.605 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F9
Represents the weighted average sale price of the shares sold from $68.61 to $69.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。